Gene therapy for retinal dystrophy nears FDA approval
admin 28th July 2017 Uncategorised 0American Academy of Ophthalmology News More: Gene therapy for retinal dystrophy nears FDA approval Source: MDlinx
read moreAmerican Academy of Ophthalmology News More: Gene therapy for retinal dystrophy nears FDA approval Source: MDlinx
read moreEuropean Society for Medical Oncology News More: FDA ODAC recommends biosimilar bevacizumab and trastuzumab Source: MDlinx
read moreNorthern Arizona University News More: Valley Fever test, developed by NAU professor Paul Keim, submitted for FDA approval Source: MDlinx
read moreEuropean Society for Medical Oncology News More: FDA grants priority review for abemaciclib in advanced breast cancer Source: MDlinx
read moreConsumer health businesses were supposed to be the safe haven in an increasingly volatile pharma world, but in the last two days, two leaders in that realm, GlaxoSmithKline and Bayer, have shown that consumer health has some of the same
read moreCancer drug Lynparza has been a bright spot for AstraZeneca amid generic competition for its blockbuster Crestor and spotty results for its pipeline. What would the company do without it? We’re about to find out how it does without half
read more© 1994 - 2024 B.M. Pharmaceuticals